Cartesian Therapeutics (RNAC) Earnings (2015 - 2026)
Cartesian Therapeutics (RNAC) earnings from Jun 30, 2015 to Mar 31, 2026. The TTM Cartesian Therapeutics (RNAC) earnings is -$152M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Cartesian Therapeutics (RNAC) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +296.27% |
| 3 Years TTM | +116.00% |
| 5 Years TTM | +15.49% |
| 10 Years TTM | +22.42% |
| All Time TTM | +23.03% |
Annual Earnings change of Cartesian Therapeutics (RNAC)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$39M | -69.93% |
| 2025 | -$130M | +68.30% |
| 2024 | -$77M | -64.76% |
| 2023 | -$220M | -721.00% |
| 2022 | $35M | -237.72% |
| 2021 | -$26M | -62.70% |
| 2020 | -$69M | +24.44% |
| 2019 | -$55M | -15.29% |
| 2018 | -$65M | +0.03% |
| 2017 | -$65M | +80.39% |
| 2016 | -$36M | +43.86% |
| 2015 | -$25M | +95.42% |
| 2014 | -$13M | N/A |
Comparison Cartesian Therapeutics (RNAC) five years earnings CAGR with competitors
Cartesian Therapeutics (RNAC) five years earnings CAGR is 15.50%.